The Net Margin of Innovent Biologics Inc (1801.HK) is -1.00%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | -1.00% |
| 2023-12-31 | -16.56% |
| 2022-12-31 | -47.83% |
| 2021-12-31 | -63.91% |
| 2020-12-31 | -25.97% |
| 2019-12-31 | -164.19% |
| 2018-12-31 | -60899.99% |
| 2017-12-31 | -3033.33% |
| 2016-12-31 | -3033.33% |